1. Intraperitoneal oncolytic virotherapy for patients with malignant ascites: Characterization of clinical efficacy and antitumor immune response
   Yalei Zhang et al, 2022, Molecular Therapy - Oncolytics CrossRef
2. Distinguishing the pros and cons of metabolic reprogramming in oncolytic virus immunotherapy
   Shiqun Wang et al, 2022, International Journal of Cancer CrossRef
3. The role of cancer metabolism in defining the success of oncolytic viro-immunotherapy
   Arthur Dyer et al, 2020, Cytokine & Growth Factor Reviews CrossRef
4. Chimeric Antigen Receptor-T Cell and Oncolytic Viral Therapies for Gastric Cancer and Peritoneal Carcinomatosis of Gastric Origin: Path to Improving Combination Strategies
   Courtney Chen et al, 2023, Cancers CrossRef
5. Overcoming immunosuppression in bone metastases
   Zachary Z. Reinstein et al, 2017, Critical Reviews in Oncology/Hematology CrossRef
6. Modifying oncolytic virotherapy to overcome the barrier of the hypoxic tumor microenvironment. Where do we stand?
   Sara Shayan et al, 2022, Cancer Cell International CrossRef
7. Recent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year update
   Sébastien A. Felt et al, 2017, Journal of General Virology CrossRef